Search

Search Results
Results 3101 - 3110 of 9444 for emergency medicine
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Vimpat Tablets and Oral Solution intended for persons living in Australia.
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Giotrif intended for persons living in Australia.
  • News - 30 Oct 2025
    The World Health Organization (WHO) condemns the reported killing of more than 460 patients and their companions, as well as the abduction of six health workers, on 28 October from the Saudi Maternity...
  • Drug - 30 Oct 2025
    Consumer Medicine Information (CMI) about Pirfenidet intended for persons living in Australia.
  • Drug - 28 Oct 2025
    Consumer Medicine Information (CMI) about Mayne Pharma Oxycodone IR intended for persons living in Australia.
  • News - 27 Oct 2025
    A multinational collaboration at Eitri medical innovation center in Bergen, Norway, has used machine learning models to identify patient groups at risk of being mistreated.
  • Drug - 23 Oct 2025
    Consumer Medicine Information (CMI) about Mizart HCT (New) intended for persons living in Australia.
  • Drug - 23 Oct 2025
    Consumer Medicine Information (CMI) about Inpler intended for persons living in Australia.
  • Drug - 21 Oct 2025
    Consumer Medicine Information (CMI) about Retevmo intended for persons living in Australia.
  • Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Itovebi intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.